Osteoporosis 101

Understanding Bone Loss, Risk, Detection, and Modern Treatment

Written by: Lennard M. Goetze, Ed.D

Osteoporosis is often dismissed as an inevitable condition of “old age,” something quietly waiting in the background of later life. That misconception alone has delayed diagnosis and prevention for millions. In reality, bone loss begins decades earlier—often in a person’s 30s and 40s—silently progressing long before the first fracture occurs. By the time osteoporosis is discovered, the damage is frequently advanced. This makes education not just useful, but essential. Understanding how and why bone density declines—and who is truly at risk—can shift osteoporosis from a reactive diagnosis to a preventable condition.

Equally important is the evolving landscape of solutions. Today’s management goes far beyond calcium supplements and generic advice. Advanced screening tools, risk modeling, and a new generation of therapies—including targeted biologics like Denosumab and bone-building agents such as Romosozumab—are redefining how clinicians approach bone health. Meanwhile, younger populations—including cancer survivors, individuals with hormonal imbalances, and those exposed to chronic stress or inflammatory conditions—are increasingly recognized as vulnerable. Osteoporosis is not just an “elderly disease”; it is a lifelong process with early warning signs, measurable risks, and, importantly, actionable interventions.

 

WHAT IS OSTEOPOROSIS?

Osteoporosis is a chronic skeletal disorder characterized by reduced bone mass and deterioration of bone microarchitecture, leading to increased fragility and fracture risk. Often called a “silent disease,” it progresses without symptoms until a fracture occurs—most commonly in the hip, spine, or wrist. These fractures can be life-altering, particularly in older adults, where recovery is prolonged and complications can be significant.

 

At its core, osteoporosis reflects an imbalance in the body’s natural bone remodeling process. Bone is living tissue, constantly broken down (resorption) by cells called osteoclasts and rebuilt (formation) by osteoblasts. When resorption outpaces formation over time, bones become porous, brittle, and prone to injury.

---

 

How Does Osteoporosis Develop?

Bone density typically peaks in early adulthood (late 20s to early 30s). After that, a gradual decline begins. In some individuals, this loss accelerates due to hormonal changes, nutritional deficiencies, or underlying health conditions.

 

A major driver of osteoporosis is declining estrogen levels, particularly in postmenopausal women. Estrogen plays a key role in preserving bone density; its reduction leads to increased bone breakdown. Men are also affected, though typically later in life, often due to declining testosterone levels.

 

Other contributors include:

• Calcium and Vitamin D deficiency (critical for bone mineralization)
• Sedentary lifestyle
• Smoking and excessive alcohol use
• Chronic corticosteroid use
• Endocrine disorders (e.g., thyroid disease)
• Inflammatory conditions (e.g., rheumatoid arthritis)
• Malabsorption syndromes

---

 

WHO IS AT RISK?

While osteoporosis can affect anyone, certain populations are at significantly higher risk:

• Women over age 50 (especially postmenopausal)
• Older men (typically over age 65–70)
• Individuals with a family history of fractures or osteoporosis
• Those with low body weight or small frame
• Patients on long-term steroid therapy
• Cancer survivors undergoing chemotherapy or hormone therapies

 

Ethnicity also plays a role—Caucasian and Asian populations have higher prevalence rates compared to African American and Hispanic populations.

---

HOW IS OSTEOPOROSIS DETECTED?

The gold standard for diagnosing osteoporosis is the dual-energy X-ray absorptiometry (DEXA) scan, which measures bone mineral density (BMD). Results are reported as a T-score:

• Normal: T-score ≥ -1.0
• Osteopenia (low bone mass): T-score between -1.0 and -2.5
• Osteoporosis: T-score ≤ -2.5

 

In addition to DEXA, clinicians may use:

• FRAX score (Fracture Risk Assessment Tool) to estimate 10-year fracture risk
• Quantitative ultrasound (screening tool)
• Advanced imaging (CT-based bone density or MRI in select cases)

 

Laboratory testing may also be used to evaluate underlying causes (e.g., calcium, vitamin D, thyroid function, parathyroid hormone).

---

 

PREVENTION: BUILDING AND PRESERVING BONE

Prevention strategies focus on maximizing peak bone mass early in life and minimizing bone loss later:

 

1. Nutrition

• Adequate calcium intake (1,000–1,200 mg/day)
• Vitamin D supplementation (800–2,000 IU/day depending on levels)

 

2. Exercise

• Weight-bearing activities (walking, jogging)
• Resistance/strength training
• Balance training to reduce fall risk

 

3. Lifestyle Modifications

• Smoking cessation
• Limiting alcohol intake
• Fall-proofing the home environment

 

4. Early Screening

• Women ≥65 and men ≥70 should undergo routine bone density testing
• Earlier screening for high-risk individuals

---

 

TREATMENT OPTIONS: MEDICATIONS THAT STRENGTHEN BONE

Modern osteoporosis treatment includes several classes of medications designed to either slow bone loss or stimulate new bone formation.

 

1. Antiresorptive Agents (Slow Bone Breakdown)

• Alendronate (Fosamax)
• Risedronate (Actonel)
• Zoledronic acid (Reclast)

These bisphosphonates are first-line therapies. They bind to bone and inhibit osteoclast activity, reducing bone loss and fracture risk.

• Denosumab (Prolia)
  A monoclonal antibody that inhibits RANKL, a protein essential for osteoclast formation. Administered as a subcutaneous injection every 6 months, it is highly effective in increasing bone density and reducing fractures.

---

 

2. Anabolic (Bone-Building) Therapies

• Teriparatide (Forteo)
• Abaloparatide (Tymlos)

These drugs stimulate osteoblast activity and are used in patients with severe osteoporosis or high fracture risk.

• Romosozumab (Evenity)
  A newer agent that both increases bone formation and decreases resorption. Given monthly for up to 12 months.

---

 

3. Hormonal and Selective Therapies

• Raloxifene (Evista)
  Mimics estrogen’s protective effects on bone without some of the risks associated with hormone replacement therapy.
• Estrogen therapy (used selectively in postmenopausal women)

---

 

WHAT ABOUT SERMORELIN?

Sermorelin is sometimes discussed in anti-aging and wellness settings. It stimulates the release of growth hormone, which can have indirect effects on bone metabolism. However, it is not FDA-approved for osteoporosis treatment and lacks robust clinical evidence compared to established therapies. It may have a supportive role in broader metabolic or longevity programs, but it should not replace standard-of-care osteoporosis treatments.

---

 

MONITORING AND LONG-TERM MANAGEMENT

Osteoporosis management is not a one-time intervention—it requires ongoing monitoring:

• Repeat DEXA scans every 1–2 years
• Tracking bone turnover markers in select cases
• Reassessing fracture risk periodically
• Evaluating adherence to therapy

Importantly, some medications (like bisphosphonates) may be paused after several years (“drug holiday”) depending on risk, while others (like denosumab) require continuous use to maintain benefits.

---

 

THE ROLE OF IMAGING AND FUNCTIONAL ASSESSMENT

Beyond DEXA, emerging approaches emphasize functional and structural imaging, including:

• High-resolution ultrasound
• Quantitative CT
• Trabecular bone scoring

These tools may offer deeper insight into bone quality—not just density—aligning with a more personalized, precision-health model of care.

---

 

FINAL THOUGHTS

Osteoporosis is highly prevalent but also highly manageable—especially when detected early. The combination of lifestyle optimization, targeted pharmacologic therapy, and proactive screening can significantly reduce fracture risk and preserve quality of life.

 

For clinicians and patients alike, the message is clear: bone health is not passive—it is measurable, modifiable, and essential to longevity.

 

How “Happy Hormones” Power Strength, Recovery, and the Human Will to Move

 The Chemistry of Momentum

By: Noelle Cutter, PhD   |   Lennard Goetze, Ed.D   |   Barbara Bartlik, MD

Modern exercise science has evolved far beyond the visible mechanics of muscle contraction and calorie burn. Beneath every squat, every repetition, and every step forward lies a deeper biological symphony—one governed not only by physiology, but by chemistry. At the center of this process are a group of powerful biochemical messengers often referred to as “happy hormones”: dopamine, serotonin, endorphins, and oxytocin.

These compounds are not simply feel-good byproducts of movement. They are active participants in the body’s adaptation to exercise, shaping everything from muscle development and metabolic balance to emotional resilience and long-term behavioral consistency. What emerges is a compelling truth: exercise is not just physical training—it is biochemical conditioning of the human system.

---

The Hormonal Quartet: A Functional Overview

The interplay between these four key neurochemicals reveals a coordinated system designed to reward movement, reduce stress, and reinforce survival behaviors.

ENDORPHINS, released during physical exertion, act as natural analgesics. They blunt pain signals and create a sense of euphoria, often referred to as the “runner’s high.” This is not incidental—it is evolutionary. The body rewards sustained effort by reducing discomfort, enabling continued performance under stress.

DOPAMINE, often labeled the “reward molecule,” is closely tied to motivation, achievement, and reinforcement learning. Every completed set, every small win in a training session, triggers dopamine release, strengthening the neural pathways that encourage repetition of that behavior.

SEROTONIN plays a stabilizing role. It regulates mood, sleep cycles, and appetite while supporting emotional equilibrium. Exercise-induced increases in serotonin are strongly associated with reduced anxiety and improved psychological balance.

OXYTOCIN, while less discussed in exercise physiology, becomes particularly relevant in social or guided training environments. It reinforces trust, connection, and emotional bonding—factors that significantly enhance adherence to fitness routines.

Together, these compounds form a biochemical feedback loop: movement produces reward, reward reinforces behavior, and behavior drives adaptation.

---

Beyond Mood: The Biochemical Role in Strength Training

While these hormones are often associated with mood enhancement, their role in strength training extends into deeper biochemical territory.

Exercise—particularly resistance training—creates controlled stress within muscle tissue. This stress activates a cascade of physiological responses, including protein synthesis, hormonal signaling, and neural adaptation. The “happy hormones” serve as modulators within this system.

Dopamine enhances neuromuscular efficiency by improving focus and motor coordination. This is critical during strength training, where precise movement patterns determine both safety and effectiveness. Increased dopamine activity can improve performance quality, allowing for better recruitment of muscle fibers.

Endorphins reduce the perception of fatigue and discomfort, enabling longer or more intense training sessions. This increased workload directly correlates with hypertrophy (muscle growth) and endurance capacity.

Serotonin contributes to recovery by regulating sleep cycles. Deep, restorative sleep is when growth hormone release peaks and tissue repair accelerates. Without adequate serotonin balance, recovery is compromised, limiting gains regardless of training intensity.

Oxytocin, though subtle in its direct muscular effects, plays a significant role in adherence. Individuals who feel supported, guided, or socially connected in their training environments are more likely to remain consistent—a key determinant of long-term strength development.

---

 

Direct vs. Indirect Influence: Do Hormones Build Muscle?

A critical question arises: are these hormones directly responsible for muscle growth, or are they indirect facilitators? The answer lies in a hybrid model.

From a strictly biochemical standpoint, muscle hypertrophy is primarily driven by mechanical tension, metabolic stress, and hormonal responses such as testosterone and growth hormone. The “happy hormones” are not the primary anabolic drivers.

However, their influence is profound in an indirect—but essential—way. They regulate behavior. They determine whether an individual shows up consistently, pushes through discomfort, and maintains the psychological resilience required for progressive overload. In this sense, they are not building muscle directly—but they are enabling the conditions under which muscle can be built.

Without dopamine, motivation falters. Without endorphins, pain becomes limiting. Without serotonin, recovery suffers. Without oxytocin, adherence declines. Thus, these hormones act as the architects of consistency, and consistency is the true engine of physical transformation.

---

Mental Health and Exercise: A Biochemical Antidepressant

The relationship between exercise and mental health is no longer anecdotal—it is clinically recognized. Depression, anxiety, and chronic stress are often associated with dysregulation of dopamine and serotonin pathways. Exercise offers a natural, non-pharmacological method to restore balance within these systems.

Regular physical activity increases baseline levels of serotonin and dopamine, while simultaneously reducing cortisol, the body’s primary stress hormone. This creates a neurochemical environment that favors emotional stability and resilience.

Endorphins provide immediate relief from stress and discomfort, offering a rapid shift in mood even after a single session. Over time, repeated exposure to these biochemical states rewires the brain, reinforcing healthier emotional patterns. This is not simply “feeling better.” It is neuroplasticity in action.

---

 

The Missing Link: Positivity, Hope, and the Power of Continuity

Perhaps the most underappreciated aspect of exercise physiology is not mechanical or biochemical—it is psychological. At the center of sustained fitness behavior lies a powerful, often overlooked force: hope.

HOPE is not abstract. It is a functional driver of consistency. It represents the belief that effort will lead to improvement, that change is possible, and that the body is capable of recovery and growth.

Biochemically, hope is reinforced by dopamine. Every small success—lifting slightly heavier weight, walking a bit farther, recovering a bit faster—triggers a reward response. This creates a feedback loop where progress fuels belief, and belief fuels continued effort.

Positivity amplifies this effect. A positive mindset enhances the perception of progress, making individuals more likely to recognize incremental improvements rather than fixate on limitations. This is particularly critical in populations recovering from illness, injury, or long-term inactivity. For these individuals, progress is often slow and nonlinear. Without a foundation of hope, adherence becomes fragile.

Hope transforms exercise from a task into a mission. It shifts the narrative from obligation to opportunity. It reframes effort as investment rather than burden. And most importantly, it sustains engagement long enough for physiological change to occur.

 

EXTRA:

Clinical Acceleration & Neuromuscular Awakening

By: HealthTech Reporter

 

In the evolving landscape of rehabilitation and performance science, new technologies are emerging that aim to accelerate the body’s natural adaptive processes. One such innovation is electromuscle stimulation (EMS), exemplified by systems like Visionbody.

Dr. Robert L. Bard’s firsthand experiences with this technology offer a compelling case study in rapid neuromuscular reactivation. Working alongside strength trainer Ellen Tyson, Dr. Bard underwent a series of EMS-assisted sessions designed to stimulate dormant muscle groups. The results were striking.

Within just three to four sessions, he reported a significant improvement in muscle engagement and functional mobility—progress that allowed him to transition from reliance on a walker to independent movement. This outcome highlights a critical concept: the body often retains latent capacity that is not readily accessible through voluntary activation alone.

EMS technology bypasses traditional neural pathways, directly stimulating muscle fibers through electrical impulses. This can “wake up” underutilized or inhibited muscles, particularly in individuals recovering from injury, neurological impairment, or prolonged inactivity. From a biochemical perspective, this rapid activation likely enhances the release of the same “happy hormones” associated with voluntary exercise.

The experience of immediate improvement generates a surge in dopamine, reinforcing the behavior. The reduction in physical limitation decreases stress, lowering cortisol levels. The renewed sense of capability fosters positivity and hope—further strengthening adherence.

Ellen Tyson’s role as a strength trainer is equally significant. Her guidance provides structure, encouragement, and accountability—elements that amplify oxytocin-mediated bonding and trust. This human connection enhances the overall effectiveness of the intervention. What emerges is a powerful synergy:

• Technology activates the body
• Biochemistry reinforces the experience
• Human guidance sustains the process

This triad represents a new frontier in rehabilitation—one that aligns perfectly with the principles of image-guided and performance-based recovery models.

---

 

Conclusion: The Invisible Engine of Human Performance

Exercise is often evaluated by visible outcomes—muscle tone, weight loss, endurance. But the true engine of transformation lies beneath the surface. The release of dopamine, serotonin, endorphins, and oxytocin is not incidental. It is foundational. These compounds shape behavior, regulate emotion, and create the internal conditions necessary for sustained effort and adaptation.

They do not simply make exercise enjoyable. They make it possible. And when combined with emerging technologies, structured training, and a foundation of hope, they become catalysts for profound recovery and growth. In the end, strength is not just built in the muscles.

It is built in the chemistry of belief, the biology of persistence, and the unwavering decision to keep moving forward.

REBUILDING STRENGTH, RESTORING IDENTITY

Why Strength Training Must Stand at the Center of Cancer Recovery

By Dr. Noelle Cutter

 

There is a moment in every athlete’s life when performance defines identity. It is not just about competition or training—it is about who you are when your body is working, responding, improving. Now imagine that identity interrupted. A diagnosis. A treatment plan. A forced pause. For many athletes, especially those facing cancer, this interruption is not just physical—it is deeply psychological.

 

What I have come to understand, both through my work and my lived observations, is that recovery is not simply about survival. It is about restoration. And at the center of that restoration—far more than we currently acknowledge—sits strength training.

 

We often default to endurance-based models when we think about exercise: running, cycling, long-duration cardiovascular work. These are valuable, no question. But when we look more closely at what athletes—and particularly cancer survivors—actually need, a different picture begins to emerge. Strength training is not just a supplement. It is foundational.

 

 

Strength Training vs. Endurance: A Critical Distinction

Endurance exercise has long been associated with the release of endorphins—the so-called “runner’s high.” It is effective, but it is also transient. Anyone who has completed a long-distance run knows that the experience is not uniformly positive. There are peaks and valleys, moments of motivation followed by fatigue, even frustration.

 

Strength training, in contrast, offers a different physiological and psychological profile. The workouts are shorter. More focused. More controlled. And the effects—particularly at the neurochemical level—appear to be more sustained.

 

From what we are beginning to understand, strength training promotes the release of dopamine, serotonin, endorphins, and oxytocin in ways that extend beyond the workout itself. It is not just about how you feel during the session—it is about how you feel hours later, even the next day. That sustained elevation matters. It builds consistency. It builds adherence. And most importantly, it builds confidence.

 

For someone recovering from cancer, this distinction is everything.

 

 

The Power of Frequency and Sustainability

One of the most powerful aspects of strength training is its accessibility. You do not need hours each day. In fact, you do not want them. Two to three sessions per week, done correctly, can produce meaningful changes—not just in muscle, but in mindset.

 

This is particularly important in populations that are rebuilding. After cancer treatment, energy is often limited. Motivation can be fragile. The idea of committing to long, exhaustive workouts can be overwhelming. Strength training removes that barrier.

 

Shorter sessions. Measurable progress. Clear endpoints. These are not small details—they are the difference between participation and avoidance. When someone can complete a session, feel stronger, and carry that feeling forward into the next day, we begin to create momentum. And momentum is what drives recovery.

 

Strength as a Universal Foundation

Regardless of the sport—whether someone is a triathlete, a runner, a cyclist, or simply someone trying to return to daily function—strength training underpins everything. Muscle is not isolated. When we rebuild muscle, we are rebuilding systems. We are supporting cardiovascular health. We are enhancing neurological function. We are improving metabolic efficiency. We are stabilizing joints and preventing injury.

 

In cancer recovery, this becomes even more significant. Treatments often deplete muscle mass. They alter metabolism. They affect coordination and balance. Strength training addresses all of these deficits simultaneously. It is not an add-on. It is the base.

 

 

The Missing Piece: Long-Term Neurochemical Impact

Despite all of this, there remains a gap in our understanding. We know that strength training influences neurotransmitters. We know that it improves mood. But we do not yet fully understand the long-term neurochemical adaptations that occur with consistent resistance training. This is an area that demands further research.

 

If we can quantify how strength training sustains dopamine or serotonin levels over time, we can begin to position it not just as physical rehabilitation, but as a core psychological intervention. We can begin to prescribe it with the same intention that we prescribe medication. And for populations dealing with anxiety, depression, or post-treatment emotional fatigue, that could be transformative.

 

 

Reclaiming the Athlete Identity

For athletes, recovery is not just about regaining physical capacity—it is about reclaiming identity.

When a diagnosis occurs, especially something as disruptive as cancer, the athlete is often stripped of the very behaviors that define them. Training stops. Competition disappears. The body feels unfamiliar, unpredictable.

 

What replaces that identity?

This is where strength training becomes more than exercise. It becomes a bridge. Each session is an opportunity to reconnect with the body. To experience control. To see progress. To feel capable again. These are not abstract benefits—they are deeply psychological anchors. Exercise provides emotional regulation. It restores self-worth. It creates a sense of normalcy in a time that is anything but normal. And perhaps most importantly, it reintroduces the idea that improvement is still possible.

 

Exercise Oncology: A New Frontier

The integration of exercise into cancer care—what we now refer to as exercise oncology—is gaining traction, but we are still at the beginning. What excites me most about this field is its potential to redefine recovery. Not as a passive process, but as an active, participatory one.

 

For young patients, and especially for athletes, the goal cannot simply be remission. It must be restoration. A return to sport. A return to function. A return to self. Strength training plays a central role in this.

It allows us to rebuild systematically. To progress safely. To track improvements. And to do so in a way that supports both physical and emotional resilience. We are not just helping patients survive—we are helping them re-engage with life.

 

Returning Stronger Than Before

There is a narrative that often surrounds cancer recovery: that the goal is to return to baseline. To get back to where you were. I challenge that.

 

What if the goal is not to return—but to rebuild beyond? With the right approach, with structured strength training, with proper nutrition and support, there is an opportunity for patients to come back stronger. More aware of their bodies. More intentional in their training. More resilient in their mindset. This is not unrealistic. It is already happening. But it requires a shift in how we think.

 

We must move away from viewing exercise as optional. As something to be added if time allows. Instead, we need to recognize it as a central component of care.

 

Recovery as Reclamation

At its core, this is about reclamation. Reclaiming strength. Reclaiming identity. Reclaiming control. When I think about the athletes I work with, and the patients navigating recovery, I do not see fragility. I see potential. I see individuals who, with the right tools, can redefine what recovery looks like.

 

Strength training is one of those tools. Perhaps the most powerful one we have yet to fully embrace.

It is time we give it the attention it deserves. Because recovery is not just about surviving what happened. It is about building what comes next.